Clinical Trials on IgAN in New Zealand
Total 39 results
-
Arrowhead PharmaceuticalsRecruitingIgA NephropathyNew Zealand
-
Eledon PharmaceuticalsTerminatedIgA Nephropathy | IgANAustralia, Spain, Thailand, New Zealand, Croatia, Malaysia, Philippines, Poland, Sri Lanka, United Kingdom
-
Ionis Pharmaceuticals, Inc.CompletedPrimary IgA NephropathyCanada, Australia, New Zealand, Singapore
-
Visterra, Inc.CompletedImmunoglobulin A Nephropathy | Glomerular Disease | IgANUnited States, Australia, Canada, Hong Kong, India, Japan, Korea, Republic of, Malaysia, Philippines, Singapore, Spain, Sri Lanka, Taiwan, Thailand, United Kingdom
-
Arrowhead PharmaceuticalsRecruitingIgA Nephropathy | C3 GlomerulopathyNew Zealand, Australia, Korea, Republic of, Thailand, Germany, United Kingdom, Georgia
-
Alexion Pharmaceuticals, Inc.RecruitingImmunoglobulin A Nephropathy | IgANSpain, United Kingdom, United States, Italy, Korea, Republic of, Belgium, Germany, Colombia, Japan, China, France, Saudi Arabia, Thailand, Australia, Canada, Brazil, Malaysia, Poland, Taiwan, Austria, Greece, Israel, Netherlands, Arge... and more
-
Alexion Pharmaceuticals, Inc.RecruitingLupus Nephritis | Immunoglobulin A Nephropathy | IgAN | LNAustralia, Spain, United Kingdom, China, Germany, Italy, Argentina, Peru, Korea, Republic of, Taiwan, Thailand, United States, Serbia, Israel, Brazil, Turkey, Mexico, Russian Federation
-
Mayo ClinicMallinckrodtCompletedProteinuria | Progressive IgA NephropathyUnited States
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompleted
-
The George InstitutePeking University First HospitalCompletedIgA GlomerulonephritisCanada, China, Australia, Malaysia, Hong Kong, India
-
Mayo ClinicColumbia University; Genentech, Inc.; Stanford University; Ohio State University; Bioge... and other collaboratorsCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedIgA NephropathyUnited States, Japan, United Kingdom
-
Novartis PharmaceuticalsCompletedIgA NephropathyColombia, Taiwan, Czechia, India, Turkey, Belgium, Netherlands, Singapore, Australia, Korea, Republic of, Thailand, Argentina, Germany, Israel, Japan, Sweden, United Kingdom, Brazil, China, Hong Kong, Norway, Finland, France, Denmark, M...
-
Omeros CorporationUnknownLupus Nephritis | IgAN | C3 Glomerulopathy | MNUnited States, Hong Kong
-
Chinook Therapeutics U.S., Inc.Active, not recruitingImmunoglobulin A Nephropathy | IgA NephropathyUnited States, Spain, Taiwan, Hong Kong, China, New Zealand, United Kingdom, Korea, Republic of, Canada, Australia, Germany, France, India, Japan, Argentina, Italy, Brazil, Colombia, Poland, Portugal
-
Columbia UniversityNovartis PharmaceuticalsTerminatedDiabetic Nephropathy | Focal Segmental Glomerulosclerosis | IgA Nephropathy | Glomerulonephritis, Membranous | Hypertensive Nephrosclerosis | Proteinuric Kidney Disease | Glomerulopathy (Obesity-associated)United States
-
Hoffmann-La RocheRecruitingPrimary IgA NephropathyKorea, Republic of, Australia, Spain, United Kingdom, Taiwan, China, Japan, France, United States, Italy, Greece, Czechia, Singapore, Argentina, Germany, Brazil, Poland, Canada
-
The George InstitutePeking University Institute of NephrologyRecruitingKidney Diseases | Glomerulonephritis | ESRD | IgA NephropathyAustralia, China, Canada, Hong Kong, India, Malaysia
-
HI-BioCompletedImmunoglobulin A (IgA) NephropathyUnited Kingdom, Germany, Spain, Serbia, Taiwan, Australia, Japan, Korea, Republic of, Belgium, United States, Bulgaria, Czechia, Georgia, Malaysia, Philippines, Ukraine
-
Chinook Therapeutics, Inc.Active, not recruitingIgA NephropathyKorea, Republic of, United States, United Kingdom
-
Calliditas Therapeutics ABCompletedPrimary IgA NephropathyUnited States, Australia, Taiwan, Spain, Canada, Argentina, Belarus, Belgium, Czechia, Finland, France, Germany, Greece, Italy, Korea, Republic of, Poland, Sweden, Turkey, United Kingdom
-
Novartis PharmaceuticalsRecruitingPrimary IgA NephropathyJapan, Korea, Republic of, United States, Denmark, France, Taiwan, Belgium, Israel, Thailand, Germany, India, Czechia, Malaysia, Argentina, Singapore, China, Australia, Norway, Turkey, United Kingdom, Brazil, Hong Kong, Netherlands, C... and more
-
Otsuka Pharmaceutical Development & Commercialization...Active, not recruitingImmunoglobulin A NephropathyUnited States
-
Chinook Therapeutics, Inc.RecruitingImmunoglobulin A Nephropathy | IgA NephropathyUnited States, Canada, Australia, Argentina, Korea, Republic of
-
Novartis PharmaceuticalsActive, not recruitingIgA NephropathyUnited States, Taiwan, Czechia, Germany, Hungary, India, Turkey, Belgium, Netherlands, Singapore, Australia, Canada, Italy, Korea, Republic of, Spain, Thailand, Denmark, Slovenia, United Kingdom, Argentina, Brazil, Israel, Japan, France, Swed... and more
-
Omeros CorporationTerminatedIgA NephropathyUnited States, Argentina, Australia, Belgium, Bulgaria, Canada, Czechia, Germany, Greece, Hungary, India, Italy, Korea, Republic of, Lithuania, Poland, Singapore, Slovakia, Spain, Sweden, Taiwan, Thailand, Turkey, United Kingdom
-
Otsuka Pharmaceutical Development & Commercialization...Enrolling by invitationImmunoglobulin A NephropathyUnited States
-
Apellis Pharmaceuticals, Inc.Active, not recruitingLupus Nephritis | IgA Nephropathy | Membranous Nephropathy | C3 Glomerulonephritis | Dense Deposit DiseaseUnited States
-
Chinook Therapeutics, Inc.RecruitingImmunoglobulin A Nephropathy | IgA NephropathySpain, United States, Australia, Korea, Republic of, Brazil, Malaysia
-
Travere Therapeutics, Inc.RecruitingImmunoglobulin A NephropathyUnited States, Hong Kong
-
Travere Therapeutics, Inc.Active, not recruitingImmunoglobulin A NephropathyUnited States, Australia, Belgium, Croatia, Czechia, Estonia, France, Germany, Hong Kong, Italy, Korea, Republic of, Lithuania, New Zealand, Poland, Portugal, Spain, Taiwan, United Kingdom
-
The Rogosin InstituteWeill Medical College of Cornell University; New York Presbyterian HospitalRecruitingKidney Diseases | Diabetic Nephropathy | Kidney Failure, Chronic | Lupus Nephritis | Glomerulonephritis, IGAUnited States
-
Travere Therapeutics, Inc.CompletedFocal Segmental Glomerulosclerosis | Immunoglobulin A NephropathyUnited States, Spain, Germany
-
AlexionRecruitingLupus Nephritis | Immunoglobulin A NephropathyUnited States, Australia, Canada, France, Germany, Italy, Korea, Republic of, Netherlands, Poland, Singapore, Spain, Sweden, Taiwan, United Kingdom
-
Travere Therapeutics, Inc.RecruitingFocal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | Minimal Change Disease | Alport Syndrome | IgA VasculitisUnited States, Italy, Netherlands, Poland, Spain, United Kingdom, Germany, Sweden
-
Chinook Therapeutics U.S., Inc.Active, not recruitingDiabetic Kidney Disease | Focal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | IgA Nephropathy | Diabetic Nephropathy Type 2 | Alport SyndromeUnited States, Spain, Korea, Republic of, Australia, Italy, United Kingdom
-
Alpine Immune Sciences, Inc.RecruitingLupus Nephritis | Immunoglobulin A Nephropathy | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Membranous NephropathyUnited States, Australia, Korea, Republic of, Austria, Norway, Spain, United Kingdom
-
University of PennsylvaniaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsRecruitingIgA Vasculitis | Henoch-Schönlein Purpura | Cutaneous Polyarteritis Nodosa | Primary Cutaneous VasculitisUnited States, Canada, Japan
-
Reata, a wholly owned subsidiary of BiogenCompletedFocal Segmental Glomerulosclerosis | IgA Nephropathy | Autosomal Dominant Polycystic Kidney | CKD Associated With Type 1 DiabetesUnited States